Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke

Launched by JUKKA PUTAALA · Oct 17, 2018

Keywords

ClinConnect Summary

The CARDIOSTROKE trial is exploring how mobile technology can help manage high blood pressure and detect heart conditions in patients who have recently experienced a stroke or a mini-stroke (known as a transient ischemic attack). Specifically, the study compares the use of mobile devices to standard care for monitoring and controlling these cardiovascular risk factors. This research aims to see if using mobile technology can better empower patients to take control of their health.

To participate in this trial, individuals must be at least 40 years old and have either had an ischemic stroke or a transient ischemic attack, along with a history of high blood pressure. Participants will be asked to provide consent and may receive support through mobile devices to help manage their condition. However, those with certain heart conditions, a pacemaker, or other serious health issues may not be eligible. Overall, this trial offers a chance to explore new ways to improve health outcomes for people at risk of cardiovascular problems.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Ischemic stroke or transient ischemic attack (ABCD2 score ≥3)
• • Age ≥40 years
• • Pre-existing or newly diagnosed hypertension
• • Informed consent from the patient or legal representative
• Exclusion Criteria:
• • Known high-risk source of cardioembolism
• • Known indication for anticoagulation
• • Contraindication for anticoagulation
• • Pacemaker
• • Non-compliance to study interventions as judged by the investigator
• • Serious condition hampering the study conduct